{"transactions":[{"id":2252652,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T17:19:43.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":32050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of (i) the date of the 2023 Annual Meeting (or the date immediately prior to the 2023 Annual Meeting if the Reporting Person's service as a director ends at such Annual Meeting), or (ii) May 26, 2023, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date."}],"balance_after":32050,"derivative":{"exercise_price":5.76,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":32050},"source":{"system":"sec-edgar","filing":"0001209191-22-032655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919122032655/doc4.xml","form_type":"4"}},{"id":2252651,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T17:19:43.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":16210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs will vest in full on the earlier of (i) the date of the 2023 Annual Meeting (or the date immediately prior to the 2023 Annual Meeting if the Reporting Person's service as a director ends at such Annual Meeting), or (ii) May 26, 2023, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date."}],"balance_after":571894,"source":{"system":"sec-edgar","filing":"0001209191-22-032655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919122032655/doc4.xml","form_type":"4"}},{"id":2291623,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-22T18:43:25.000Z","date":"2022-04-20","kind":"other","acquired":true,"shares":125967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase of securities, from GV 2016 LP to the Reporting Person without additional consideration."}],"balance_after":555684,"source":{"system":"sec-edgar","filing":"0001209191-22-025453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919122025453/doc4.xml","form_type":"4"}},{"id":2297476,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T17:57:20.000Z","date":"2022-04-11","kind":"other","acquired":true,"shares":125967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase of securities, from GV 2016 LP to the Reporting Person without additional consideration."}],"balance_after":429717,"source":{"system":"sec-edgar","filing":"0001209191-22-024325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919122024325/doc4.xml","form_type":"4"}},{"id":2431738,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T18:13:28.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":8320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of (i) the date of the 2022 Annual Meeting (or the date immediately prior to the 2022 Annual Meeting if the Reporting Person's service as a director ends at such Annual Meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election), or (ii) January 14, 2023, subject in all cases to the Reporting Person's continued service as a member of the Board of Director through such vesting date."}],"balance_after":8320,"derivative":{"exercise_price":12.93,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":8320},"source":{"system":"sec-edgar","filing":"0001209191-22-003797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919122003797/doc4.xml","form_type":"4"}},{"id":2431737,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-19T18:13:28.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award.  The RSUs will vest in full on the earlier of (i) the date of the 2022 Annual Meeting (or the date immediately prior to the 2022 Annual Meeting if the Reporting Person's service as a director ends at such Annual Meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election), or (ii) January 14, 2023, subject in all cases to the Reporting Person's continued service as a member of the Board of Director through such vesting date."}],"balance_after":303750,"source":{"system":"sec-edgar","filing":"0001209191-22-003797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919122003797/doc4.xml","form_type":"4"}},{"id":2551184,"issuer":{"id":3350,"kind":"organization","name":"IonQ, Inc.","symbol":"IONQ"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"Byers Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:34:15.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":300000,"price":10,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased from the Issuer in a private placement."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001209191-21-059175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741840/000120919121059175/doc4.xml","form_type":"4"}},{"id":3116455,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"BYERS BLAKE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T20:30:45.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 5, 2021 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":9.99,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-20-015805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320015805/doc4.xml","form_type":"4"}},{"id":3494325,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"BYERS BLAKE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-11T21:03:41.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 7, 2020 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":13.4,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-19-016410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924319016410/doc4.xml","form_type":"4"}},{"id":3882351,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"BYERS BLAKE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-06-27T20:25:31.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":8494864,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares.  Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P.  Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares.  Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P.  Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3287511},"source":{"system":"sec-edgar","filing":"0000899243-18-018319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018319/doc4.xml","form_type":"4"}},{"id":3882350,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"BYERS BLAKE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-06-27T20:25:31.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":133400,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares.  Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P.  Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares.  Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P.  Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":51626},"source":{"system":"sec-edgar","filing":"0000899243-18-018319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018319/doc4.xml","form_type":"4"}},{"id":3882349,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":126787,"kind":"person","name":"Byers Blake","position":1,"cik":"0001741840","reported_name":"BYERS BLAKE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T20:25:31.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":3339137,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares.  Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P.  Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares.  Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P.  Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose."}],"balance_after":3339137,"source":{"system":"sec-edgar","filing":"0000899243-18-018319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018319/doc4.xml","form_type":"4"}}]}